@article {Koks2021.11.03.21265851, author = {Sulev Koks and Abigail L. Pfaff and Vivien J. Bubb and John P. Quinn}, title = {Longitudinal intronic RNA-seq analysis of Parkinson{\textquoteright}s Disease patients reveals disease-specific genome-wide nascent transcription}, elocation-id = {2021.11.03.21265851}, year = {2021}, doi = {10.1101/2021.11.03.21265851}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Transcriptomic studies usually focus on gene or exon-based annotations, and only limited experiments have reported the changes in the reads mapping to introns. The analysis of intronic reads allows the detection of nascent transcription that is not influenced by steady -state RNA levels and provides information on actively transcribed genes.Methods Here we describe substantial intronic transcriptional changes in Parkinson{\textquoteright}s Disease (PD) patients compared to healthy controls (CO) at two different timepoints, at the time of diagnosis (BL) and three years later (V08). We used blood RNA-seq data from the Parkinson{\textquoteright}s Progression Markers Initiative (PPMI) cohort subjects and identified significantly changed transcription of intronic reads only in PD patients during this follow up time.Results In CO subjects, only nine transcripts demonstrated differentially expressed introns between visits BL and V08. However, in PD patients 4,873 transcripts had differentially expressed introns at visit V08 compared to BL, many of them with clear connection to neurodegenerative diseases, such as LRRK2, C9orf72, LGALS3, KANSL1AS1, ALS2. In addition, at the time of diagnosis (BL visit) we identified 836 transcripts (e.g. SNCA, DNAJC19, PRRG4) and at visit V08 2,184 transcripts (e.g. PINK1, GBA, ALS2, PLEKHM1) with differential intronic expression specific to PD patients. In contrast, reads mapping to exonic regions demonstrated little variation indicating high specificity of changes in intronic transcription.Conclusion Our study shows that Parkinson{\textquoteright}s disease is characterized by substantial changes in the nascent transcription and description of these changes could help to understand the molecular pathology underpinning this disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by MSWA, The Michael J. Fox Foundation, Shake It Up Australia and Perron Institute for Neurological and Translational Science.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://www.ppmi-info.org/data In this study we used the Parkinson Progression Markers Initiative (PPMI) cohort data that were downloaded from www.ppmi-info.org/data. The PPMI is a longitudinal cohort of Parkinson patients with the aims to describe the progression and biomarkers of Parkinson disease.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://www.ppmi-info.org.}, URL = {https://www.medrxiv.org/content/early/2021/11/16/2021.11.03.21265851}, eprint = {https://www.medrxiv.org/content/early/2021/11/16/2021.11.03.21265851.full.pdf}, journal = {medRxiv} }